434 related articles for article (PubMed ID: 30442330)
21. Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b.
Kumar S; Naqvi RA; Khanna N; Pathak P; Rao DN
Clin Immunol; 2011 Nov; 141(2):133-42. PubMed ID: 21807564
[TBL] [Abstract][Full Text] [Related]
22. E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation.
Qiao G; Ying H; Zhao Y; Liang Y; Guo H; Shen H; Li Z; Solway J; Tao E; Chiang YJ; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2014 Feb; 6(4):709-23. PubMed ID: 24508458
[TBL] [Abstract][Full Text] [Related]
23. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
[TBL] [Abstract][Full Text] [Related]
24. T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.
Vos WG; van Os BW; den Toom M; Beckers L; van Roomen CPAA; van Tiel CM; Mohapatra BC; Band H; Nitz K; Weber C; Atzler D; de Winther MPJ; Bosmans LA; Lutgens E; Seijkens TTP
Front Immunol; 2024; 15():1297893. PubMed ID: 38504977
[TBL] [Abstract][Full Text] [Related]
25. E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination.
Zhao Y; Guo H; Qiao G; Zucker M; Langdon WY; Zhang J
J Immunol; 2015 Feb; 194(4):1639-45. PubMed ID: 25560411
[TBL] [Abstract][Full Text] [Related]
26. Cbl-b in T-cell activation.
Paolino M; Penninger JM
Semin Immunopathol; 2010 Jun; 32(2):137-48. PubMed ID: 20458601
[TBL] [Abstract][Full Text] [Related]
27. E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation.
Yang WX; Jin R; Jiang CM; Wang XH; Shu J; Li L; Zhu LH; Zhuang LL; Gao C; Zhou GP
FEBS Lett; 2015 Jul; 589(15):1975-80. PubMed ID: 26112603
[TBL] [Abstract][Full Text] [Related]
28. A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.
Stürner KH; Borgmeyer U; Schulze C; Pless O; Martin R
J Immunol; 2014 Nov; 193(9):4439-47. PubMed ID: 25261476
[TBL] [Abstract][Full Text] [Related]
29. Negative regulation of lymphocyte development and function by the Cbl family of proteins.
Huang F; Gu H
Immunol Rev; 2008 Aug; 224():229-38. PubMed ID: 18759930
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin ligase Cbl-b and inhibitory Cblin peptides.
Nikawa T; Ishidoh K
Biochim Biophys Acta Proteins Proteom; 2020 Nov; 1868(11):140495. PubMed ID: 32663526
[TBL] [Abstract][Full Text] [Related]
31. c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth.
Lyle C; Richards S; Yasuda K; Napoleon MA; Walker J; Arinze N; Belghasem M; Vellard I; Yin W; Ravid JD; Zavaro E; Amraei R; Francis J; Phatak U; Rifkin IR; Rahimi N; Chitalia VC
Sci Rep; 2019 Dec; 9(1):20257. PubMed ID: 31882749
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin Ligases CBL and CBL-B Maintain the Homeostasis and Immune Quiescence of Dendritic Cells.
Tong H; Li X; Zhang J; Gong L; Sun W; Calderon V; Zhang X; Li Y; Gadzinski A; Langdon WY; Reizis B; Zou Y; Gu H
Front Immunol; 2021; 12():757231. PubMed ID: 34630435
[TBL] [Abstract][Full Text] [Related]
33. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
[TBL] [Abstract][Full Text] [Related]
34. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.
Jeon MS; Atfield A; Venuprasad K; Krawczyk C; Sarao R; Elly C; Yang C; Arya S; Bachmaier K; Su L; Bouchard D; Jones R; Gronski M; Ohashi P; Wada T; Bloom D; Fathman CG; Liu YC; Penninger JM
Immunity; 2004 Aug; 21(2):167-77. PubMed ID: 15308098
[TBL] [Abstract][Full Text] [Related]
35. Suppressive functions of B cells in infectious diseases.
Shen P; Fillatreau S
Int Immunol; 2015 Oct; 27(10):513-9. PubMed ID: 26066008
[TBL] [Abstract][Full Text] [Related]
36. Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.
Lu T; Chen L; Mansour AG; Yu MJ; Brooks N; Teng KY; Li Z; Zhang J; Barr T; Yu J; Caligiuri MA
J Immunol; 2021 Feb; 206(4):677-685. PubMed ID: 33419766
[TBL] [Abstract][Full Text] [Related]
37. Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice.
Shi ZD; Li XF; Hao L; Zhao Y; Wang YX; Dong BZ; Chen WH; Zhang ZG; Wang YM; Fu Q; Han CH; Li S
Eur Rev Med Pharmacol Sci; 2014; 18(24):3819-30. PubMed ID: 25555872
[TBL] [Abstract][Full Text] [Related]
38. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.
Fang D; Liu YC
Nat Immunol; 2001 Sep; 2(9):870-5. PubMed ID: 11526404
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
40. Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.
Schmitz ML
Sci Signal; 2009 Jun; 2(76):pe38. PubMed ID: 19549983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
